Global Urinary Catheters Market (2020 to 2025) - Emerging Economies are Presenting Opportunities


Dublin, Oct. 14, 2020 (GLOBE NEWSWIRE) -- The "Urinary Catheters Market by Product (Indwelling, Intermittent, External), Type (Coated, Uncoated), Application (Urinary Incontinence, Benign Prostate Hyperplasia, General Surgery), Usage (Male, Female), End Users (Hospitals) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global urinary catheters market size is projected to reach USD 2.6 billion by 2025 from USD 2.0 billion in 2020, at a CAGR of 5.5% during the forecast period.

Market growth can be largely attributed to factors such as the growing prevalence of urinary incontinence, an increasing number of surgical procedures across the globe, high incidence of prostate cancer, and the favorable reimbursement scenario. The emerging Asian countries are also expected to offer strong growth opportunities for players in the market. The untapped market opportunities in emerging markets are also expected to provide growth opportunities for players in the market. On the other hand, the complications associated with catheterization and the availability of alternative treatment options for urinary incontinence may restrict market growth to a certain extent.

Based on end-users, the global urinary catheters market is segmented into hospitals, long-term care facilities, and other end users. Hospitals accounted for the largest share of the urinary catheters market in 2019. The large share of this end-user segment can be attributed to the large volume of patients visiting hospitals due to the rising prevalence of ailments requiring surgical treatment and the high incidence of chronic diseases such as urinary incontinence, multiple sclerosis, and spina bifida.

The urinary incontinence application segment will witness the highest growth in the urinary catheters market.

Based on application, the global urinary catheters market is segmented into urinary incontinence, general surgery, benign prostatic hyperplasia, and other applications. The urinary incontinence segment accounted for the largest share of the urinary catheters market in 2019. This segment is also expected to witness the highest CAGR during the forecast period. The large share and high growth of this segment can primarily be attributed to the increasing incidence of urinary incontinence, the growing geriatric population, and the rising incidence of obesity.

North America will dominate the market during the forecast period.

Geographically, the urinary catheters market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. In 2019, North America accounted for the largest share of the urinary catheters market. The large share of this region can be attributed factors such as the high prevalence of diseases, growing geriatric population, the availability of advanced interventional products (including urinary catheters), and increasing surgical procedures performed in the region are driving market growth in North America.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Urinary Catheters Market Overview
4.2 Asia-Pacific: Urinary Catheters Market, by Application & Country (2019)
4.3 Urinary Catheters Market, by End-user, 2019
4.4 Urinary Catheters Market: Geographic Snapshot

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Prevalence of Urinary Incontinence
5.2.1.1.1 Increasing Rates of Obesity
5.2.1.1.2 Rapidly Increasing Geriatric Population
5.2.1.2 High Incidence of Prostate Cancer
5.2.1.3 Increasing Number of Surgical Procedures
5.2.1.4 Favorable Reimbursement Scenario
5.2.2 Restraints
5.2.2.1 Complications Associated with Catheterization and the Availability of Alternatives
5.2.3 Opportunities
5.2.3.1 Emerging Economies
5.2.4 Trends
5.2.4.1 Growing Preference for Single-Use Catheters and Self-Catheterization
5.2.5 Covid Impact
5.3 Pricing Analysis
5.4 Value Chain Analysis
5.5 Supply Chain Analysis
5.6 Ecosystem Analysis of the Urology Devices Market

6 Urinary Catheters Market, by Product
6.1 Introduction
6.2 Indwelling Catheters
6.2.1 Indwelling Catheters to Dominate the Urinary Catheters Market During the Forecast Period
6.3 Intermittent Catheters
6.3.1 Intermittent Catheters Segment to Grow at the Highest CAGR During the Forecast Period
6.4 External Catheters
6.4.1 Advantages Such as Minimized Risk of Damage to the Urethra to Drive the Market for External Catheters

7 Urinary Catheters Market, by Type
7.1 Introduction
7.2 Coated Catheters
7.2.1 Coated Catheters Are the Largest and Fastest-Growing Segment in the Urinary Catheters Market
7.3 Uncoated Catheters
7.3.1 Affordable Price and Easy Availability to Drive the Market for Uncoated Catheters

8 Urinary Catheters Market, by Usage
8.1 Introduction
8.2 Male Urinary Catheters
8.2.1 High Incidence of Prostate Cancer to Drive the Market for Male Urinary Catheters
8.3 Female Urinary Catheters
8.3.1 High Prevalence of Urinary Incontinence to Drive the Market for Female Urinary Catheters

9 Urinary Catheters Market, by Application
9.1 Introduction
9.2 Urinary Incontinence
9.2.1 Urinary Incontinence Application Segment to Dominate the Market During the Forecast Period
9.3 General Surgery
9.3.1 Increasing Number of Surgeries to Drive Market Growth
9.4 Benign Prostatic Hyperplasia
9.4.1 Growing Global Prevalence of Benign Prostatic Hyperplasia to Drive the Demand for Urinary Catheters
9.5 Other Applications

10 Urinary Catheters Market, by End-user
10.1 Introduction
10.2 Hospitals
10.2.1 High Patient Influx and Procedural Volumes Make Hospitals the Largest End-users of Urinary Catheters
10.3 Long-Term Care Facilities
10.3.1 Growing Demand for Long-Term Care Supports the Growth of this End-User Segment
10.4 Other End-users

11 Urinary Catheters Market, by Region
11.1 Introduction
11.2 North America
11.3 Europe
11.4 Asia-Pacific
11.5 RoW

12 Competitive Landscape
12.1 Overview
12.2 Competitive Situations and Trends
12.2.1 Partnerships & Agreements
12.2.2 Product Launches & Approvals
12.2.3 Expansions
12.2.4 Acquisitions

13 Company Evaluation Matrix and Company Profiles
13.1 Company Evaluation Matrix Definitions and Methodology
13.1.1 Market Share Analysis, 2019
13.2 Company Evaluation Matrix
13.2.1 Stars
13.2.2 Emerging Leaders
13.2.3 Pervasive Players
13.2.4 Participants
13.3 Competitive Leadership Mapping (Start-Ups)
13.3.1 Progressive Companies
13.3.2 Starting Blocks
13.3.3 Responsive Companies
13.3.4 Dynamic Companies
13.4 Company Profiles
13.4.1 Coloplast A/S
13.4.2 Becton, Dickinson and Company (Bd)
13.4.3 Convatec Group plc
13.4.4 Cardinal Health
13.4.5 B. Braun Melsungen Ag
13.4.6 Boston Scientific Corporation
13.4.7 Asid Bonz Gmbh
13.4.8 Bactiguard
13.4.9 Cook Medical
13.4.10 Cure Medical
13.4.11 Go Medical Industries Pty Ltd.
13.4.12 Hollister Incorporated
13.4.13 Teleflex Incorporated
13.4.14 Wellspect Healthcare (A Subsidiary of Dentsply Sirona Inc.)
13.5 Other Companies
13.5.1 Amsino International, Inc.
13.5.2 Compactcath
13.5.3 Degania Silicone Ltd. (A Part of Q Life Sciences)
13.5.4 Hunter Urology
13.5.5 J and M Urinary Catheters LLC
13.5.6 Manfred Sauer Gmbh
13.5.7 Medical Technologies of Georgia
13.5.8 Ribbel International Limited
13.5.9 Rocamed
13.5.10 Urocare Products, Inc.
13.5.11 Well Lead Medical Co. Ltd.

14 Appendix
14.1 Discussion Guide
14.2 Knowledge Store: Subscription Portal
14.3 Available Customizations
14.4 Related Reports
14.5 Author Details

For more information about this report visit https://www.researchandmarkets.com/r/43o4pp

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

 

Coordonnées